These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients. Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT. Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504 [Abstract] [Full Text] [Related]
11. Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study. Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A. Transplant Proc; 2009 Oct; 41(8):3308-10. PubMed ID: 19857737 [Abstract] [Full Text] [Related]
17. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C. Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973 [Abstract] [Full Text] [Related]
18. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Nair S, Eason J, Loss G. Liver Transpl; 2003 Feb; 9(2):126-9. PubMed ID: 12548505 [Abstract] [Full Text] [Related]